Novel mutation detection of regulatory molecule dopamine gene receptors (D1-D5) encoding analysis on human peripheral blood lymphocytes in schizophrenia patients

European Journal of Inflammation

Volumn 7, Issue 3, 2009, Pages 145-152

  Ahangari, G ^a   Shariati, G H ^a,b   Asadi, M R ^c   Ostadali, M R ^d   Ahmadkhaniha, H R ^e,f  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Dopamine gene receptor; Mutation; Reverse transcription and peripheral blood lymphocytes; Schizophrenia

Indexed keywords

BETA ACTIN; DOPAMINE RECEPTOR; GENOMIC DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRD 1 GENE; DRD 2 GENE; DRD 3 GENE; DRD 4 GENE; DRD 5 GENE; GENE; GENE MUTATION; HUMAN; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

EID: 70949100464     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727x0900700304     Document Type: Article

References (25)

1. Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L. Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates B1 integrin function. Eur J Immunol 2001; 31:3504-3512 (Pubitemid 34030963)
2. Bergquist TJ, Tarkowski A, Ekman R, Ewing A. Discovery of endogenous catecholamine in lymphocytes and evidence for catecholamine regulation of lymphocytes function via an autocrine loop. Proc Natl Acad Sci 1994; 91:12912-12916
3. Takahashi N, Nagai Y, Ueno S, Saeki Y, Takehiko Y. Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudo genes. FEBS 1992; 314:1023-1025
4. Ferrari M, Cosentino M, Marino F, Bombelli R, Rasini E, Lecchini S, Frigo G. Dopaminergic D1-like receptor dependent inhibition of tyrosine hydroxyl's mRNA expression and catecholamine production in human lymphocytes. Biochem Pharmacol 2004; 67: 865-873 (Pubitemid 38201632)
5. Ostadali MR, Ahangari G. The detection of dopamine gene receptors (DRD1-DRD5) expression on human peripheral blood lymphocytes by real time PCR. Iran J Allergy Asthma Immunol 2004; 3:169-174
6. Cosentino M, et al. Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis. J Neuroimmunol 2003; 13:233-240 (Pubitemid 35346746)
7. Parsons MJ, Mata I, Beperet M, Iribarren-Iriso F, Arroyo B, Sainz R, Arranz MJ, Kerwin R. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 2007; 17:159-163 (Pubitemid 46716208)
8. Lung FW, Chen N, Shu BC. Dopamine D4 receptor gene and the -521C>T polymorphism of the upstream region of the dopamine D4 receptor gene in schizophrenia. Psychiatr Genet 2006; 16:139-143 (Pubitemid 44491780)
9. Meerabux J, Iwayama Y, Sakurai T, et al. Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects. Biol Psychiatry 2005; 58:401-407 (Pubitemid 41219708)
10. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak-Weglarz M, Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm 2005; 112:1575-1582 (Pubitemid 41504271)
11. Hong CJ, Liu HC, Liu TY, Liao DL, Tsai SJ. Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia.. J Neural Transm 2005; 112:1503-1510
12. Ahangari G, Tehrani MJ, Halapi E, Hammar H, Wigzell H. RT-PCR based analysis of T-cell receptor B variable region gene usage in normal human SKIN. Scand J Immunol 1996; 44:330-334
13. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual, Cold Spring Harbor laboratory press USA, 2003; p. 433-527.
14. Monakhov M, Golimbet V, Abramova L, Kaleda V, Karpov V. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res 2008; 100: 302-307
15. Ma G, He Z, Fang W, et al. The ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta analysis. Schizophr Res 2008; 101:26-35.
16. Shah M, Coon H, Holik J, Hoff M, Helmer V, Panos P, Byerley W. Mutation scan of the D1 dopamine receptor gene in 22 cases of bipolar disorder. Am J Med Genet 1995 24; 60:150-153
17. Basu S, Dasguta PS. Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000; 102:113-124
18. Josefsson E, Bergquist J, Ekman R, Tarkowski A. Catecholamine are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 1996; 88:140-146 (Pubitemid 26166387)
19. Levite M. Nerve-Driven immunity. Ann NY Acad Sci 2000; 917:307-321
20. Blakely RD, Dopamine's reversal of fortune. Science 2001; 293:2400-2409
21. Kwak YT, Koo M, Choi C, Sunwoo IN. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med Genet 2001; 2: 1-3. (Pubitemid 38692953)
22. Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur R, Joyce J. Mesolimbic dopamine D3 receptors and use of antipsychotic in patients with schizophrenia. Arch Gen Psychiatry 1997; 54:223-232
23. Nagai Y, Ueno S, Saeki Y, Soga F, Hirano M, Yanagihara T. Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 1996; 46:791-795 (Pubitemid 26099651)
24. Inoue A, Nakata Y. Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy. Jpn J Pharmacol 2001; 86:376-380 (Pubitemid 32888259)
25. Jakel R, Maragos WF. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci 2000; 23:239-245 (Pubitemid 30331108)